UPCOMING WEBINARS
Alongside recent research of HCPs and Consumers, The DHC Group has surveyed pharma marketers. This webinar will review and analyze how marketers are currently using and evaluating direct-to-patient programs in order to help the industry continue to apply innovation opportunities to improve patient health outcomes.
Haven’t taken the survey yet? https://dhcg.questionpro.com/t/ALVy9Z6phG
Panelists Include:
- Matt Walsh, General Manager, BioPharma, ixlayer
- Andrew Smith, VP, Consulting, Klick
- Chuck Sachs, Director, US Commercial Innovation, AstraZeneca
Behind every prescription is a person—and for patients prescribed specialty medications, the path to getting started and staying on therapy can be anything but simple.
Join this upcoming DHCG webinar to walk through the full patient experience using a real-world therapy example.
We’ll examine the complex challenges providers and patients face—and proven solutions that drive real results. From greater, brand-specific transparency in provider workflows to personalized patient support at moments that matter, end-to-end engagement technology improves prescription completion rates and patient outcomes.
Panelists Include:
- Colin Banas, M.D., M.H.A., Chief Medical Officer, DrFirst
- Caleb Dunn, PharmD, Clinical Product Manager, DrFirst
- Chad Maeder, Senior Director, Patient Experience and Operations CNS/Neurology/Nephrology, Otsuka Precision Health
Learn how to apply the latest omnichannel strategy using breakthrough physician behavioral research and expert implementation guidance.
Join leading pharmaceutical marketing experts for an exclusive deep-dive into omnichannel innovation that bridges Medical Affairs scientific rigor with commercial marketing effectiveness.
This session combines insights from physician preference data from 499+ global HCPs with practical implementation strategies from seasoned practitioners.
Panelists Include:
- Dr. Shivang Joshi, Neurologist and Sermo Medical Advisory Board
- Erin Fitzgerald, CMO, Sermo
- Anurag Gupta MD MBA, Senior Director – DS&AI Products / Digital Health – Oncology Commercial and Medical Affairs, AstraZeneca (Additional experts to be announced)
- Tim Jones, Vice President, Strategic Operations, Deployment Solutions – Syneos Health
ON-DEMAND WEBINARS
DHC Group Webinar - Omnichannel Innovation and Measurement: Research and Analysis
This webinar will share the exclusive release of the latest DHCG survey results, Omnichannel Innovation and Measurement, as well as research highlights and feature a panel of experts discussing how marketers are currently defining the “ideal” state of “omnichannel marketing”, as well as what KPIs or metrics are most important for both brands and senior leadership reporting in order to track and measure progress towards that ideal state.
Panelists Include:
- Theresa Greco, CCO, OptimizeRx
- Kristen Vayda-Dreitlein, Head of Omnichannel, Type 1 Diabetes, Sanofi
- Bill Veltre, EVP, Head of Media, Deerfield Group
- Andrew Burkus, Senior Director, IQVIA Digital
DHC Group Webinar - Lessons in DTC from Women's Health: What menopause Teaches Us About the Future of Patient Access
From fertility to menopause, we’re witnessing a surge of consumer-driven innovation—but many offerings still rely on transactional, one-time care models. The next wave of transformation lies in building longitudinal, whole-person care that’s personalized, accessible, and scalable.
This webinar brings together leaders Michelle Davey (Founder and CEO, Wheel), Dorothy Gemmell (Chief Commercial Officer and President, GoodRx), Elizabeth Gluck (Associate Director, US Biosimilars, Organon) and Amy Turnquist (VP, North America Operating Board, HBA & Partner, Life Sciences, BIP) as moderator to explore how consumer-driven direct-to-consumer (DTC) programs are enabling this shift. Using menopause as a case study—and drawing from new data on the financial burden facing women—we’ll examine how pharma brands can use DTC as a launchpad for sustainable, branded care models centered on continuity, clinical rigor, and patient trust.
Thought leaders will unpack how DTC infrastructure can:
- Help pharma brands rapidly launch patient-centric programs that are cash-pay ready and compliant
- Move beyond transactional care to support long-term engagement and outcomes
- Unlock new channels for commercialization in under-served or emerging categories like menopause
- Build trust and transparency with patients through brand-owned pricing and access experiences
- Future-proof access strategy in the face of tightening regulation, shifting patient expectations, and payer complexity
Menopause is just the starting point. We’ll also explore how this evolution applies beyond women’s health. Whether you’re focused on chronic conditions, specialty therapies, access gaps, or launching a new treatment, this discussion offers a proven model for how DTC can unlock growth, compliance, and patient loyalty across therapeutic areas.
DHC Group x Healio Strategic Solutions Webinar: AI, Oncology, and HCP Information Discovery
This webinar for pharmaceutical industry executives will feature industry leaders Dr. Hansa Bhargava (Healio/Physician), Anthony Manson (Healio), Simon Smith (Klick), and Michael Sivak (AstraZeneca) as they explore the rapidly evolving role of artificial intelligence (AI) in oncology, with a focus on how oncologists are leveraging AI platforms to search, access and synthesize medical literature, clinical news and information at the point of care.
Key discussion points include:
- Real-Time Literature and Guideline Integration: AI platforms integrate the latest clinical research, national guidelines, and institution-specific protocols, providing oncologists with up-to-date, evidence-based recommendations during patient visits. This reduces the time spent searching for and reviewing literature, enhancing decision-making efficiency.
- Enhanced Search and Decision Support: AI tools can rapidly scan vast databases of medical journals and research, identifying relevant studies, biomarkers, and treatment options tailored to individual patients. This enables more precise and personalized care, especially as new therapies and diagnostics emerge.
- Continuous Learning: These platforms are designed to learn and update dynamically, incorporating new research findings and guideline changes to ensure oncologists always work with the most current evidence.
This session will offer insights into how pharmaceutical leaders can align their strategies with these technological advancements, anticipate future needs, and support the integration of AI-driven tools in oncology practices
DHCG x Underscore Marketing Webinar - It's Not Just About ROI
In today’s complex omnichannel landscape, traditional “look back” ROI analyses only tell part of the story. Focusing on both retrospective and prospective insights—such as uncovering more precise behavioral HCP segments and their information needs, quantifying how digital and personal channels complement each other, and using in-market tests to confirm where and how to scale—provides better visibility into key optimization levers. These insights help increase the promotional sales impact. Join Underscore thought leaders Tiffany Marg, Kate Miller, and Brandi Ascione, the Digital Health Coalition, and Ally Sager (Puma Biotechnology) for a roundtable on how advanced analytics can uncover what’s really driving performance—and how to turn those insights into scalable, measurable growth.
DHC Group Live Roundtable Series - Data, Privacy, and AI in Pharma
At this industry roundtable on data, privacy, and AI, thought leaders Jonathan Zile (PulsePoint), Ted Sweetser (PurpleLab), Jonathan McLeod (Throtle), Lauren Lawhon (HealthUnion), Tyler Doppelheuer (IQVIA), and Alison Tapia (Former Dermavant) as moderator discuss how evolving data privacy regulations are reshaping data strategies in the industry. Leaders shared insights on leveraging AI and first-party data to drive innovation while ensuring compliance with HIPAA, GDPR, and other standards. The conversation also highlights the challenges of integrating diverse data sources, maintaining patient trust, and deploying ethical AI solutions. Executives also explore the transformative potential of generative AI and real-time analytics for targeting and customer engagement in a privacy-first landscape.
DHC Group Webinar - Reimagining Patient Acquisition
Xander Kerman Gregory (Ubie) and Halle Marchese (Nucleus Genomics) share groundbreaking strategies that are reshaping how brands connect with patients. Hear insights from this brand leader and lessons learned applying innovative tech to educate and engage patients. You’ll walk away with practical tactics you can implement right away!
This session explores:
- Best Practices – How Nucleus Genomics has leveraged communities, influencers, and events to drive patient acquisition—what’s worked, what hasn’t, and key takeaways.
- Beyond the Cutting Edge – How Ubie is redefining engagement by reaching patients earlier, delivering content they seek, and using innovative channels.
- What Works Best – Key learnings and actionable insights to refine your pharma marketing strategy.
DHC Group Webinar - Unlock the Power of NPs & PAs in Your HCP Marketing Strategy
Industry experts Nathan Lenyszyn (VP of Marketing, HealthLink Dimensions), Dawn Lacallade (Chief Strategy Officer, LiveWorld), and Vince Milano (Executive Director, Assertio Therapeutics) unveil the latest research from 360 surveyed NPs and PAs, providing fresh insights into their prescribing behaviors, communication preferences, and content consumption trends. Learn how to effectively engage this growing group of Advanced Practice Providers (APPs) to build trust, enhance education, and maximize your brand’s impact on new prescriptions (NRx).
DHC Group Webinar - Exploring Best Practices for Biopharma DTP Implementation
This webinar will clarify the best practices and misconceptions around direct-to-patient (DTP) programs. We’ll address common myths, explaining how these programs operate and deliver impact, with a focus on understanding patients’ needs and expectations in today’s healthcare landscape, how DTP supports early intervention and sustained care, detailed insights into telehealth, lab testing, and prescription fulfillment, and navigating compliance and addressing implementation complexities.
Our panel of thought leaders share expert perspectives on optimizing DTP initiatives and improving patient outcomes: Matthew Walsh (General Manager Biopharma, ixlayer), Mark Gaydos (Regulatory Expert, former Sanofi), Eric McCulley (Head of Portfolio Innovation; US Immunology, UCB), Chad Meader (Senior Director, Patient Experience and Operations CNS/Neurology, Otsuka Precision Health), and Nandini Nayar (Global Digital Health and Innovation Lead, Sanofi).
DHC Group Live Roundtable Series on Data Innovation
These roundtables on data innovation will explore how pharmaceutical companies are harnessing the power of data for identity solutions, enhanced targeting, and exploring the potential of the integration of physician and consumer data. Our distinguished panel of thought leaders will share their experiences, challenges, and visions for the future.
DHC Group Live Webinar: AI & Patient Cx
As AI reaches a pivotal moment in its capabilities, this webinar explores how the technology can be harnessed to create patient-centric experiences that empower patients to take charge of their health journeys and foster deeper engagement with life science companies, with examples centered around combining human input and thoughtful design.
DHC Group Live Webinar: Patient Customer Experience
This webinar will feature a dynamic group of industry experts who will share exclusive results of the recent Patient Customer Experience in Pharma survey. They will also share the latest consumer data and best practices for key facets of patient customer experience.
DHC Group Live Webinar: Pharmacy Innovations
This webinar features the exclusive release of the Pharmacist Survey results. It also includes leading edge experts providing an industry guide to the innovation that’s possible at the pharmacy now, both patient and pharmacist-facing, as well as a clearer picture of what is coming.
Summits
are uniquely formatted events include a rapidly moving agenda, an engaged group of industry peers, newly released DHC Group research and fireside chats with thought leaders. These half-day intensives are hosted in partnership with a life science company (recent hosts include GSK, Pfizer, Genentech, and AstraZeneca) and are open to all current employees of pharma/biotech as well as DHC Group members. Learn more about the next DHCG-hosted Summit, focused on Customer Experience with Genentech.
Roundtables and Guided Discussions
are 45 – 60 minute content opportunities featuring invited DHC Group members and pharmaceutical marketers participating in an intensive discussion around a specific topic area. These sessions are filmed and summarized to be shared with the industry. Visit this summary of our recent guided discussion with Twitter and social media pharma marketers below.
Webinars
are research or case study- focused virtual content events with an engaged audience and subject matter experts. These are longer form sessions acting as a deep dive on a specific topic. Our recent webinar on AI and RWD in HCP Engagement is available below.
Events On-Demand
DHC Group event content is also made available as educational resources for pharma marketers delivered through the Digital Health Coalition and other industry partners. A sample of this event coverage is available.